Acsadi, G., Dickson, G., Love, D. R., Jani, A., Walsh, F. S., Gurusinghe, A., Wolff, J. A. and Davies, K. E (1991). Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature 352, 815-818.[Medline]
Ahn, A. H. and Kunkel, L. M (1993). The structural and functional diversity of dystrophin. Nature Genet 3, 283-291.[Medline]
Anderson, M. S. and Kunkel, L. M (1992). The molecular and biochemical basis of Duchenne muscular dystrophy. Trends Biochem. Sci 17, 289-292.[Medline]
Barton, C. H., Dickson, G., Gower, H. J., Putt, W., Elsom, V., Moore, S. E., Goridis, C. and Walsh, F. S (1988). Complete sequence and in vitro expression of a tissue-specific phosphotidylinositol-linked N-CAM isoform from skeletal muscle. Development 104, 165-173.[Abstract]
Byers, T. J., Lidov, H. G. W. and Kunkel, L. M (1993). An alternative dystrophin transcript specific to peripheral nerve. Nature Genet 4, 77-81.[Medline]
Craig, S. W. and Pardo, J. V (1983). Gamma actin, spectrin, and intermediate filament proteins colocalise with vinculin at costameres, myofibril-to-sarcolemma attachment sites. Cell Motil 3, 449-462.[Medline]
Cross, R. A., Stewart, M. and Kendrick-Jones, J (1990). Structural predictions for the central rod domain of dystrophin. FEBS Lett 262, 87-92.[Medline]
Davison, M. D. and Critchley, D. R (1988). a-Actinins and the DMD protein contain spectrin-like repeats. Cell 52, 159-160.[Medline]
Dickson, G., Love, D. R., Davies, K. E., Wells, K. E., Piper, T. A. and Walsh, F. S (1991). Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Human Genet 88, 53-58.
Dickson, G., Azad, A., Morris, G. E., Simon, H., Noursadeghi, M. and Walsh, F. S (1992). Co-localisation and molecular association of dystrophin with laminin at the surface of mouse and human myotubes. J. Cell Sci 103, 1223-1233.[Abstract/Free Full Text]
Dunckley, M. G., Love, D. R., Davies, K. E., Walsh, F. S., Morris, G. E. and Dickson, G (1992). Retroviral-mediated transfer of a dystrophin minigene into mdx myoblasts in vitro. FEBS Lett 296, 128-134.[Medline]
Dunckley, M. G., Wells, D. J., Walsh, F. S. and Dickson, G (1993). Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet 2, 717-723.[Abstract/Free Full Text]
England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love. D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B. and Davies, K. E (1990). Very mild muscular dystrophy associated with deletion of 46% of dystrophin. Nature 343, 180-182.[Medline]
Erba, H. P., Eddy, R., Shows, T., Kedes, L. and Gunning P (1988). Structure, chromosome location, and expression of the human-actin gene: differential evolution, location and expression of the cytoskeletal -and-actin genes. Mol. Cell. Biol 8, 1775-1789.[Abstract/Free Full Text]
Ervasti, J. M. and Campbell, K. P (1991). Membrane-organisation of the dystrophin-glycoprotein complex. Cell 66, 1121-1131.[Medline]
Ervasti, J. M. and Campbell, K. P (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol 122, 809-823.[Abstract/Free Full Text]
Ervasti, J. M. and Campbell, K. P (1993). Dystrophin and the membrane cytoskeleton. Curr. Opin. Cell Biol 5, 82-87.[Medline]
Helliwell, T. R., Ellis, J. M., Mountford, R. C., Appleton, R. E. and Morris, G. E (1992). A truncated dystrophin lacking the C-terminal domains is located at the muscle membrane. Amer. J. Hum. Genet 50, 508-514.[Medline]
Hemmings, L., Kuhlman, P. A. and Critchley, D. R (1992). Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain. J. Cell Biol 116, 1369-1380.[Abstract/Free Full Text]
Hoffman, E. P., Fischbeck, K. H., Brown, R. H., Johnson, M., Medori, R., Loike, J. D., Harris, J. B., Waterston, R., Brooke, M., Specht, L. et al (1988). Characterisation of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. New Engl. J. Med 318, 1363-1368.[Abstract]
Hoffman, E. P., Morgan, J. E., Watkins, S. C. and Partridge, T. A (1990). Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci 99, 9-25.[Medline]
Hoffman, E. P., Garcia, C. A., Chamberlain, J. S., Angelini, C., Lupski, J. R. and Fenwick, R (1991). Is the carboxyl terminus of dystrophin required for membrane-association? A novel, severe case of Duchenne muscular dystrophy. Ann. Neurol 30, 605-610.[Medline]
Koenig, M., Monaco, A. P. and Kunkel, L. M (1988). The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219-228.[Medline]
Koenig, M. and Kunkel, L. M (1990). Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem 265, 4560-4566.[Abstract/Free Full Text]
Lederfein, D., Levy, Z., Augier, N., Mornet, D., Morris, G., Fuchs, O., Yaffe, D. and Nudel, U (1992). A 71 kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc. Nat. Acad. Sci. USA 89, 5346-5350.[Abstract/Free Full Text]
Levine, B. A., Moir, A. J. G., Patchell, V. B. and Perry, S. V (1992). Binding sites involved in the interaction of actin with the N-terminal region of dystrophin. FEBS Lett 298, 44-48.[Medline]
Malhotra, S. B., Hart, K. A., Klamut, H. J., Thomas, N. S. T., Bodrug, S. E., Burghes, A. H. M., Bobrow, M., Harper, P. S., Thompson, M. W., Ray, P. N. and Worton, R. G (1988). Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242, 755-759.[Abstract/Free Full Text]
Matsumura, K., Nonaka, I., Tome, F. M. S., Arahata, K., Collin, H., Leturcq, F., Recan, D., Kaplan, J.-C., Fardeau, M. and Campbell, K. P (1993). Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Amer. J. Hum. Genet 53, 409-416.[Medline]
Minaschek, G., Bereiter-Hahn, J. and Bertholdt, G (1989). Quantitation of the volume of liquid injected into cells by means of pressure. Exp. Cell Res 183, 434-442.[Medline]
Morgenstern, J. P. and Land, H (1990). Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl. Acids Res 18, 3587-3596.[Abstract/Free Full Text]
Morgenstern, J. P. and Land H (1990). A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transient transfected cells. Nucl. Acids Res 18, 1068-.[Free Full Text]
Morris, G. E., Ellis, J. M. and Nguyen, t. M (1993). A quantitative ELISA for dystrophin. J. Immunol. Meth 161, 23-28.[Medline]
Ohlendieck, K. and Campbell, K. P (1991). Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol 115, 1685-1694.[Abstract/Free Full Text]
Porter, G. A., Dmytrenko, G. M., Winkelmann, J. C. and Bloch, R. J (1992). Dystrophin colocalises with-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J. Cell Biol 117, 997-1005.[Abstract/Free Full Text]
Rapaport, D., Greenberg, D. S., Tal, M., Yaffe, D. and Nudel, U (1993). Dp71, the nonmuscle product of the Duchenne muscular dystrophy gene, is associated with the cell membrane. FEBS Lett 328, 197-202.[Medline]
Recan, D., Chafey, P., Leturcq, F., Hugnot, J.-P., Vincent, N., Tome, F., Collin, H., Simon, D., Czernichow, P., Nicholson, L. V. B., Fardeau, M. and Kaplan, J.-C (1992). Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localisation?. J. Clin. Invest 89, 712-716.
Roberts, R. G., Coffey, A. J., Bobrow, M. and Bentley, D (1993). Exon structure of the human dystrophin gene. Genomics 16, 536-538.[Medline]
Sato, O., Nonomura, Y., Kimura, S. and Maruyama, K (1992). Molecular shape of dystrophin. J. Biochem 112, 631-636.
Sicinski, P., Geng, Y., Ryder-Cook, A. S., Barnard, E. A., Darlison, M. G. and Barnard, P. J (1989). The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578-1580.[Abstract/Free Full Text]
Smith, T. J., Forrest, S. M., Cross, G. S. and Davies, K. E (1987). Duchenne and Becker muscular dystrophy mutations: analysis using a 2.6kb of muscle cDNA from the 5end of the gene. Nucl. Acids Res 15, 9761-9769.[Abstract/Free Full Text]
Straub, V., Bittner, R. E., Leger, J. J. and Voit, T (1992). Direct visualisation of the dystrophin network on skeletal muscle fibre membranes. J. Cell Biol 119, 1183-1191.[Abstract/Free Full Text]
Suzuki, A., Yoshida, M., Yamamoto, H. and Ozawa, E (1992). Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxyl-terminal domain. FEBS Lett 308, 154-160.[Medline]
Turner, D. L. and Cepko, C. L (1987). A common progenitor for neurons and glia persists in rat retina late in development. Nature 328, 131-136.[Medline]
Way, M., Pope, B., Cross, R. A., Kendrick-Jones, J. and Weeds, A. G (1992). Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett 301, 243-245.[Medline]
Wells, D. J. and Goldspink, G (1992). Age and sex influence expression of plasmid DNA directly injected into mouse skeletal muscle. FEBS Lett 306, 203-205.[Medline]
Wells, D. J., Wells, K. E., Walsh, F. S., Davies, K. E., Goldspink, G., Love, D. R., Chan-Thomas, P., Dunckley, M. G., Piper, T. and Dickson, G (1992). Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum. Mol. Genet 1, 35-40.[Abstract/Free Full Text]
Wessel, H. B (1990). Dystrophin: a clinical perspective. Ped. Neurol 6, 3-12.[Medline]
Wolff, J. A., Williams, P., Acsadi, G., Jiao, S., Jani, A. and Chong, W (1991). Conditions affecting direct gene transfer into rodent muscle in vivo. BioTechniques 11, 474-485.[Medline]
